Clinical Trials Logo

Stage IV Rectal Cancer AJCC v8 clinical trials

View clinical trials related to Stage IV Rectal Cancer AJCC v8.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03765736 Terminated - Clinical trials for Stage III Rectal Cancer AJCC v8

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

Start date: April 20, 2020
Phase:
Study type: Observational

This trial screens patients with colon or rectal cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable) for genetic mutations for recommendation to a molecularly assigned therapy. Identifying gene mutations may help patients enroll onto target companion trials that target these mutations.

NCT ID: NCT03592641 Terminated - Clinical trials for Colorectal Carcinoma

Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer

Start date: July 25, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well savolitinib works in treating patients with MET amplified colorectal cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable). Savolitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.